6:09 PM
 | 
Sep 26, 2012
 |  BC Extra  |  Company News

Teijin receives Japanese rights to Pulmagen's asthma product

Pulmagen Therapeutics Ltd. (Slough, U.K.) granted Teijin Pharma Ltd. (Tokyo, Japan) exclusive rights in Japan to develop...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >